Amgen stock price slips from record close as AMGN heads into earnings and the obesity-drug race
Amgen shares ended Friday down 0.7% at $344.75, pulling back after a run that nearly took the biotech giant to record highs ahead of the weekend. About 3.8 million shares changed hands, LSEG data shows.